Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Stay updated with the latest weekly cash back credit card deals to maximize your savings. Don't miss these offers!
23,042 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Equity Residential and AvalonBay Communities have named the leadership slate for their planned all-stock merger, sign...
Victor Wembanyama encountered a hostile reception in New York after a Knicks game, with a near egging incident and la...
Retail investors are increasingly betting on celebrities in prediction markets, signaling a shift as platforms court ...
A viral duck became the centerpiece of a commercial shoot outside Azteca Stadium, but FIFA rules prevented him from s...
A high-stakes NBA scenario puts investor attention on payroll, sponsorships, and market bets. The potential LeBron mo...
Backlog in the commercial space economy just reached a pivotal $500 billion mark as SpaceX began trading on NASDAQ, s...
Retirees eyeing lower living costs are turning to Spain's Costa Blanca. This report weighs whether $500,000 can cover...
A Cytokinetics insider sale coincides with a stunning stock move. This article breaks down what the trade might signa...
A leading hedge fund poured nearly $40 million into GRAIL last quarter, only to see the stock tumble. This article un...
Brown Harris Stevens adds Debbie Baum, a seasoned Manhattan real estate broker, from Corcoran. The move expands the f...
NVIDIA signals a potential shift in its OpenAI investment with new discussions about winding down the stake. The news...